Table 3.
Baseline characteristics of subjects by quartiles of TG
| TG (mmol/l) | Q1(≤0.80) (n = 1279) |
Q2(> 0.80, ≤ 1.20) (n = 1326) |
Q3(> 1.20, ≤ 1.70) (n = 1284) |
Q4(> 1.70) (n = 1294) |
P value |
|---|---|---|---|---|---|
| Age (Years) | 39(18) | 48(25)* | 52(23)*# | 53(20)*#※ | < 0.001 |
| Male (%) | 551(43.1) | 764(57.6)* | 870(67.8)*# | 991(76.6)*#※ | < 0.001 |
| BMI (kg/m2) | 21.53 ± 2.54 | 22.68 ± 2.76* | 23.81 ± 2.93*# | 24.95 ± 2.74*#※ | < 0.001 |
|
Overweight (24 ≤ BMI < 28) (%) |
176(13.8) | 384(29.0)* | 504(39.3)*# | 667(51.5)*#※ | < 0.001 |
| Obesity (BMI ≥ 28) (%) | 21(1.6) | 34(2.6)* | 97(7.6)*# | 159(12.3)*#※ | < 0.001 |
| SBP (mmHg) | 117.94 ± 16.05 | 123.20 ± 18.31* | 127.34 ± 18.35*# | 133.42 ± 17.97*#※ | < 0.001 |
| DBP (mmHg) | 70.91 ± 10.34 | 73.53 ± 10.74* | 76.83 ± 10.75*# | 80.94 ± 10.88*#※ | < 0.001 |
| TC (mmol/L) | 4.39 ± 0.79 | 4.71 ± 0.83* | 4.99 ± 0.92*# | 5.23 ± 0.93*#※ | < 0.001 |
| HDL-C (mmol/L) | 1.48 ± 0.31 | 1.36 ± 0.29* | 1.24 ± 0.26*# | 1.10 ± 0.22*#※ | < 0.001 |
| LDL-C (mmol/L) | 2.45 ± 0.64 | 2.79 ± 0.70* | 2.94 ± 0.79*# | 3.04 ± 0.76*#※ | < 0.001 |
| BUN (mmol/L) | 4.95 ± 1.20 | 4.97 ± 1.15 | 5.01 ± 1.12* | 5.06 ± 1.09*# | 0.052 |
| FPG (mmol/L) | 5.04 ± 0.56 | 5.16 ± 0.76* | 5.26 ± 0.73*# | 5.49 ± 1.10*#※ | < 0.001 |
| SCr (μmol/L) | 77.74 ± 13.81 | 81.56 ± 13.46* | 84.63 ± 12.86*# | 87.32 ± 12.81*#※ | < 0.001 |
| SUA (mg/dl) | 4.96 ± 1.12 | 5.36 ± 1.27* | 5.80 ± 1.25*# | 6.35 ± 1.32*#※ | < 0.001 |
| Hypertension (%) | 89(7.0) | 168(12.7)* | 253(19.7)*# | 339(26.2)*#※ | < 0.001 |
| Diabetes (%) | 29(2.3) | 39(2.9)* | 56(4.4)*# | 74(5.6)*#※ | < 0.001 |
| eGFR (ml/min/1.73m2) | 92.36 ± 16.27 | 86.79 ± 14.98* | 83.71 ± 13.87*# | 82.09 ± 13.96*#※ | < 0.001 |
| New incident CKD (%) | 39(3.0) | 37(2.8)* | 54(4.2)*# | 97(7.5)*#※ | < 0.001 |
*Compared with Q1 group, P < 0.05. #Compared with Q2 group, P < 0.05. ※Compared with Q3 group, P < 0.05